VNRX insider trading
NYSE American HealthcareVOLITIONRX LTD: insider trade history from SEC Form 4 filings.
About VOLITIONRX LTD
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Company website: volition.com
VNRX insider activity at a glance
FilingIQ tracks 513 insider transactions for VNRX in filings since Feb 13, 2015. The most recent transaction is dated Sep 28, 2026.
Across the full history, 87 open-market purchases
and 14 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VNRX insider trades is 50.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VNRX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VNRX?
- FilingIQ tracks 513 Form 4 insider transactions for VNRX (VOLITIONRX LTD), covering filings from Feb 13, 2015 onwards. 2 of those are dated within the last 90 days.
- Are VNRX insiders net buyers or net sellers?
- Across the full Form 4 history for VNRX, 87 transactions (17%) were open-market purchases and 14 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VNRX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is VNRX in?
- VOLITIONRX LTD (VNRX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $25.28M.
Methodology & sources
Every VNRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.